Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Langerhans cell control of early-life dermal lymphatic development shapes adult immunity.
Journal: Science immunology
Published: June 26, 2026
An Injectable Alginate Hydrogel Modified by Collagen and Fibronectin for Better Cellular Environment.
Journal: ACS applied bio materials
Published: January 31, 2025
The association of hidradenitis suppurativa with cigarette smoking and cannabis use: a cross-sectional study in the All of Us Research Program.
Journal: Clinical and experimental dermatology
Published: November 15, 2024
An Update on Emerging Regenerative Medicine Applications: The Use of Extracellular Vesicles and Exosomes for the Management of Chronic Pain.
Journal: Current pain and headache reports
Published: October 18, 2024
Langerhans cells regulate immunity in adulthood by regulating postnatal dermal lymphatic development.
Journal: bioRxiv : the preprint server for biology
Published: July 29, 2024
Efficacy of laser hair removal in hidradenitis suppurativa: A systematic review and meta-analysis.
Journal: Lasers in surgery and medicine
Published: February 13, 2024
Targeting interleukin (IL)-4/IL-13 in immune checkpoint inhibitor-induced bullous pemphigoid: a cautionary note on the beneficial effect of T helper 2 immunity in melanoma and immunotherapy: reply from the authors.
Journal: The British journal of dermatology
Published: November 10, 2023
Hidradenitis suppurativa in Black and White patients - a clinical study.
Journal: European review for medical and pharmacological sciences
Published: May 02, 2023
Lymphatic dysfunction in lupus contributes to cutaneous photosensitivity and lymph node B cell responses.
Journal: The Journal of clinical investigation
Published: December 28, 2022
Immune checkpoint inhibitor-induced bullous pemphigoid is characterized by interleukin (IL)-4 and IL-13 expression and responds to dupilumab treatment.
Journal: The British journal of dermatology
Published: August 06, 2022
Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody-Positive Patients with Livedo.
Journal: The Journal of rheumatology
Published: May 17, 2022
Last Updated: 09/26/2026